Search - tctmd.com

Displaying 421 - 440 of 1184

Sort: Relevancy | Date

Presentation TCT 2014

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Ning Guo

September 15, 2014

Presentation TCT 2014

Case #8: Early Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Neal Uren

September 15, 2014

Presentation TCT 2014

Case #7: In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Fernando Alfonso

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Lisette Okkels Jensen

September 15, 2014

Presentation TCT 2014

Definitely To Prevent Stent Thrombosis and MI!

Presenter: Gregg W. Stone

September 15, 2014

Presentation TCT 2014

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux

September 15, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Industry News

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

September 15, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

September 15, 2014

News Conference News TCT 2014

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

News Conference News TCT 2014

Expert Discusses Potential Role for Platelet Function, Genetic Testing

September 15, 2014

Advertisement

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Case #8: Early Stent Thrombosis

Case #7: In-Stent Restenosis

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Definitely To Prevent Stent Thrombosis and MI!

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

Keynote Address Focuses on Newer DES, Problematic Subgroups

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

Expert Discusses Potential Role for Platelet Function, Genetic Testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content